ERADEC Trademark

Trademark Overview

On Wednesday, November 26, 2025, a trademark application was filed for ERADEC with the United States Patent and Trademark Office. The USPTO has given the ERADEC trademark a serial number of 99517928. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, July 1, 2026. This trademark is owned by Shanghai ATTEC Biotechnology Co., Ltd.. The ERADEC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicines for human purposes for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Pharmaceutical preparations for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Chemico-pharmaceutical preparations for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Drugs for medical purposes, namely, small molecule drugs for targeted protein degradation; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases via targeted protein degradation

Technical research in the field of targeted protein degradation; Research and development of new products for others; Chemical analysis; Chemical analysis services; Chemical research; Bacteriological research and development; Biological research; Medical and scientific research, namely, conducting clinical trials for others; Medical research and development of therapeutics; Pharmaceutical development
eradec

General Information

Serial Number99517928
Word MarkERADEC
Filing DateWednesday, November 26, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, July 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicines for human purposes for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Pharmaceutical preparations for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Chemico-pharmaceutical preparations for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Drugs for medical purposes, namely, small molecule drugs for targeted protein degradation; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases via targeted protein degradation
Goods and ServicesTechnical research in the field of targeted protein degradation; Research and development of new products for others; Chemical analysis; Chemical analysis services; Chemical research; Bacteriological research and development; Biological research; Medical and scientific research, namely, conducting clinical trials for others; Medical research and development of therapeutics; Pharmaceutical development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 26, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShanghai ATTEC Biotechnology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type22 - NOT AVAILABLE
AddressShanghai 201400
CN

Trademark Events

Event DateEvent Description
Wednesday, November 26, 2025NEW APPLICATION ENTERED
Wednesday, November 26, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 31, 2026ASSIGNED TO EXAMINER
Tuesday, March 31, 2026NON-FINAL ACTION WRITTEN
Tuesday, March 31, 2026NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 30, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 30, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 1, 2026TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

eradec diseases research neurodegenerative autoimmune pharmaceutical chemical development medical disorder immunological